0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Genetic aspects and latest findings

Session 1: Genetics of migraine

Aarno Palotie

M.D., Ph.D. Institute for Molecular Medicine Finland at University of Helsinki & The Broad Institute of MIT and Harvard, Cambridge, MA. USA

Download presentation

Next

Clinical Implications

You Might Also Like

Related Embedded Video Item Thumbnail Epidemiological and clinical aspects
Related Embedded Video Item Thumbnail Targeting ion channels
Related Embedded Video Item Thumbnail Societal burden of migraine
Related Embedded Video Item Thumbnail Combination therapy and switching
Related Embedded Video Item Thumbnail Safety and tolerability, wearing-off

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128